225 related articles for article (PubMed ID: 19541929)
1. Modulation of the E2F1-driven cancer cell fate by the DNA damage response machinery and potential novel E2F1 targets in osteosarcomas.
Liontos M; Niforou K; Velimezi G; Vougas K; Evangelou K; Apostolopoulou K; Vrtel R; Damalas A; Kontovazenitis P; Kotsinas A; Zoumpourlis V; Tsangaris GT; Kittas C; Ginsberg D; Halazonetis TD; Bartek J; Gorgoulis VG
Am J Pathol; 2009 Jul; 175(1):376-91. PubMed ID: 19541929
[TBL] [Abstract][Full Text] [Related]
2. FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function.
Shats I; Gatza ML; Liu B; Angus SP; You L; Nevins JR
Cancer Res; 2013 Oct; 73(19):6056-67. PubMed ID: 23966291
[TBL] [Abstract][Full Text] [Related]
3. E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry.
Alla V; Kowtharapu BS; Engelmann D; Emmrich S; Schmitz U; Steder M; Pützer BM
Cell Cycle; 2012 Aug; 11(16):3067-78. PubMed ID: 22871739
[TBL] [Abstract][Full Text] [Related]
4. Triggering of p73-dependent apoptosis in osteosarcoma is under the control of E2Fs-pRb2/p130 complexes.
La Sala D; Macaluso M; Trimarchi C; Giordano A; Cinti C
Oncogene; 2003 Jun; 22(23):3518-29. PubMed ID: 12789260
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of the E2F1 response in p53-negative cancer cells: new aspects in the regulation of cell survival and death.
Li Z; Kreutzer M; Mikkat S; Mise N; Glocker MO; Pützer BM
Proteomics; 2006 Nov; 6(21):5735-45. PubMed ID: 17001603
[TBL] [Abstract][Full Text] [Related]
6. MCPH1/BRIT1 cooperates with E2F1 in the activation of checkpoint, DNA repair and apoptosis.
Yang SZ; Lin FT; Lin WC
EMBO Rep; 2008 Sep; 9(9):907-15. PubMed ID: 18660752
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
[TBL] [Abstract][Full Text] [Related]
8. p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2.
Urist M; Tanaka T; Poyurovsky MV; Prives C
Genes Dev; 2004 Dec; 18(24):3041-54. PubMed ID: 15601819
[TBL] [Abstract][Full Text] [Related]
9. Kinetic modeling-based detection of genetic signatures that provide chemoresistance via the E2F1-p73/DNp73-miR-205 network.
Vera J; Schmitz U; Lai X; Engelmann D; Khan FM; Wolkenhauer O; Pützer BM
Cancer Res; 2013 Jun; 73(12):3511-24. PubMed ID: 23447575
[TBL] [Abstract][Full Text] [Related]
10. NEDDylation controls the target specificity of E2F1 and apoptosis induction.
Aoki I; Higuchi M; Gotoh Y
Oncogene; 2013 Aug; 32(34):3954-64. PubMed ID: 23001041
[TBL] [Abstract][Full Text] [Related]
11. Characterization of an E2F1-specific binding domain in pRB and its implications for apoptotic regulation.
Julian LM; Palander O; Seifried LA; Foster JE; Dick FA
Oncogene; 2008 Mar; 27(11):1572-9. PubMed ID: 17891180
[TBL] [Abstract][Full Text] [Related]
12. Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.
Ambrosini G; Sambol EB; Carvajal D; Vassilev LT; Singer S; Schwartz GK
Oncogene; 2007 May; 26(24):3473-81. PubMed ID: 17146434
[TBL] [Abstract][Full Text] [Related]
13. Yin Yang 1 induces transcriptional activity of p73 through cooperation with E2F1.
Wu S; Murai S; Kataoka K; Miyagishi M
Biochem Biophys Res Commun; 2008 Jan; 365(1):75-81. PubMed ID: 17980704
[TBL] [Abstract][Full Text] [Related]
14. Deregulated expression of E2F1 promotes proteolytic degradation of tumor suppressor p73 and inhibits its transcriptional activity.
Ozaki T; Okoshi R; Ono S; Kubo N; Nakagawara A
Biochem Biophys Res Commun; 2009 Sep; 387(1):143-8. PubMed ID: 19576172
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor TAp73 gene specifically responds to deregulated E2F activity in human normal fibroblasts.
Ozono E; Komori H; Iwanaga R; Tanaka T; Sakae T; Kitamura H; Yamaoka S; Ohtani K
Genes Cells; 2012 Aug; 17(8):660-72. PubMed ID: 22702391
[TBL] [Abstract][Full Text] [Related]
16. TAp73 promotes cell survival upon genotoxic stress by inhibiting p53 activity.
Chen D; Ming L; Zou F; Peng Y; Van Houten B; Yu J; Zhang L
Oncotarget; 2014 Sep; 5(18):8107-22. PubMed ID: 25237903
[TBL] [Abstract][Full Text] [Related]
17. Variation in transcriptional regulation of cyclin dependent kinase inhibitor p21waf1/cip1 among human bronchogenic carcinomas.
Harr MW; Graves TG; Crawford EL; Warner KA; Reed CA; Willey JC
Mol Cancer; 2005 Jul; 4():23. PubMed ID: 16014176
[TBL] [Abstract][Full Text] [Related]
18. E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells.
Li Y; Shao J; Shen K; Xu Y; Liu J; Qian X
J Cell Biochem; 2012 Oct; 113(10):3165-77. PubMed ID: 22593008
[TBL] [Abstract][Full Text] [Related]
19. hSirT1-dependent regulation of the PCAF-E2F1-p73 apoptotic pathway in response to DNA damage.
Pediconi N; Guerrieri F; Vossio S; Bruno T; Belloni L; Schinzari V; Scisciani C; Fanciulli M; Levrero M
Mol Cell Biol; 2009 Apr; 29(8):1989-98. PubMed ID: 19188449
[TBL] [Abstract][Full Text] [Related]
20. The c-MYC-interacting proapoptotic tumor suppressor BIN1 is a transcriptional target for E2F1 in response to DNA damage.
Cassimere EK; Pyndiah S; Sakamuro D
Cell Death Differ; 2009 Dec; 16(12):1641-53. PubMed ID: 19629135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
